Rachael Brake
Director/Board Member bei M51 Topco, Inc.
Vermögen: - $ am 31.03.2024
Profil
Rachael Brake is currently the Director at M51 Topco, Inc. She previously worked as the Head-US Medical Affairs Oncology at Millennium Pharmaceuticals, Inc. from 2014 to 2021.
She then served as the Chief Scientific Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2024.
Dr. Brake holds an undergraduate degree from The Australian National University and a doctorate degree from The University of Western Australia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Rachael Brake
| Unternehmen | Position | Beginn |
|---|---|---|
M51 Topco, Inc.
 M51 Topco, Inc. Pharmaceuticals: MajorHealth Technology M51 Topco, Inc., through its subsidiary Velsera, is a company that connects healthcare and life sciences to enable precision medicine. The company is based in Boston, MA, and has subsidiaries in the United States and Belgium. The company aims to create a continuous flow of knowledge between researchers, scientists, and clinicians worldwide to improve human health. Velsera's focus is on creating insights that can radically improve human health. Gavin Nichols has been the CEO of the company since 2022. | Director/Board Member | 27.06.2023 |
Ehemalige bekannte Positionen von Rachael Brake
| Unternehmen | Position | Ende |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 19.02.2024 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Rachael Brake
| Australian National University | Undergraduate Degree |
| The University of Western Australia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
M51 Topco, Inc.
M51 Topco, Inc. Pharmaceuticals: MajorHealth Technology M51 Topco, Inc., through its subsidiary Velsera, is a company that connects healthcare and life sciences to enable precision medicine. The company is based in Boston, MA, and has subsidiaries in the United States and Belgium. The company aims to create a continuous flow of knowledge between researchers, scientists, and clinicians worldwide to improve human health. Velsera's focus is on creating insights that can radically improve human health. Gavin Nichols has been the CEO of the company since 2022. | Health Technology |
